Reporting

CEO duality – the practice of combining the roles of the CEO and chairman of the board – has been the topic of one of the longest debates

With its rules on related party transactions (RPTs), the amended EU Shareholder Rights Directive introduces a novel ex ante review of sus

Takeovers and especially models predicting takeovers have been of interest to academics and practitioners.

This article tells the story of our shareholder class action against Teva Pharmaceutical Industries as an illustration of the global race

Government regulation on disclosure differs considerably across countries. This gives rise to some interesting research questions.